Hutchison China Meditech Limited
29 September 2006
Hutchison China MediTech Limited ('Chi-Med') (AIM: HCM)
Appointment of Senior Independent Director
London, 29 September 2006: Chi-Med today announces that it has appointed Mr.
Christopher Nash, an Independent Non-executive Director of Chi-Med since the
admission of trading of its shares on AIM in May this year, as its Senior
Independent Director.
Ends
Enquiries
Chi-Med Telephone: +852-2121-8200
Christian Hogg, CEO
Citigate Dewe Rogerson Telephone: +44 (0) 20 7638 9571
Anthony Carlisle (07973 611 888)
Chris Gardner (07903 737 649)
Yvonne Alexander (07866 610 682)
Notes to Editors
Chi-Med is the holding company of a pharmaceutical and healthcare group based
primarily in China and was admitted to trading on the Alternative Investment
Market of the London Stock Exchange in May 2006. Chi-Med is focused on
researching, developing, manufacturing, and selling pharmaceuticals, health
supplements and other consumer health and personal care products derived from
Traditional Chinese Medicine and botanical ingredients. Its overall aim is to
draw on the untapped wealth of knowledge and history of usage in the Traditional
Chinese Medicine industry to develop products for the global market. The Company
has three complementary businesses: drug R&D, China healthcare and consumer
products.
Chi-Med is majority owned by Hutchison Whampoa Limited, an international
corporation listed on the Main Board of The Stock Exchange of Hong Kong Limited.
This information is provided by RNS
The company news service from the London Stock Exchange
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.